Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01846481 · ClinicalTrials.gov registry record · Phase 2
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse
A Phase 2 study, sponsored by Indivior.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT01846481 is a Phase 2 study that has completed, run by Indivior. The registered enrollment target is 40 participants.
The verdict
NCT01846481, a Phase 2 study, has completed, sponsored by Indivior.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a randomized, 4-sequence, 2-period, double-blind, placebo controlled study in male and female subjects with an American Psychiatric Association Diagnostic and Statistical Manual DSM-IV-TR diagnosis of cocaine abuse.
Interventions
- DRUG Placebo
- DRUG Cocaine
- DRUG RBP-8000 100 mg
- DRUG RBP-8000 200 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01846481
The ClinicalTrials.gov registry entry for NCT01846481 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indivior, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01846481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01846481 about?
NCT01846481 is a clinical study titled "A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse". This is a randomized, 4-sequence, 2-period, double-blind, placebo controlled study in male and female subjects with an American Psychiatric Association Diagnostic and Statistical Manual DSM-IV-TR diagnosis of cocaine abuse.
What is the current status of trial NCT01846481?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2013-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01846481?
The interventions under investigation include: Placebo (DRUG), Cocaine (DRUG), RBP-8000 100 mg (DRUG), RBP-8000 200 mg (DRUG).
Who is sponsoring clinical trial NCT01846481?
This trial is sponsored by Indivior, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.